CAR-T Cell Therapies From the Transfusion Medicine Perspective
- 1 July 2016
- journal article
- review article
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 30 (3) , 139-145
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (CA166039, 5T32HL007775)
- National Institutes of Health
This publication has 64 references indexed in Scilit:
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid LeukemiaNew England Journal of Medicine, 2013
- Biophysical mechanism of T-cell receptor triggering in a reconstituted systemNature, 2012
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid LeukemiaNew England Journal of Medicine, 2011
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced LeukemiaScience Translational Medicine, 2011
- Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safetyLeukemia, 2010
- Accelerated Production of Antigen-specific T Cells for Preclinical and Clinical Applications Using Gas-permeable Rapid Expansion Cultureware (G-Rex)Journal of Immunotherapy, 2010
- Potency analysis of cellular therapies: the emerging role of molecular assaysJournal of Translational Medicine, 2007
- A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined ImmunodeficiencyNew England Journal of Medicine, 2003
- The rapid one-step gradient centrifugation procedure for simultaneous isolation of granulocytic and mononuclear leukocytes from human blood: Biological, physical and chemical basesMedical Hypotheses, 1983
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979